Healthcare EDI Market - Global Forecast to 2029
商品番号 : SMB-67734
| 出版社 | MarketsandMarkets |
| 出版年月 | 2025年2月 |
| ページ数 | 368 |
| 図表数 | 488 |
| 価格タイプ | シングルユーザライセンス |
| 価格 | USD 4,950 |
| 種別 | 英文調査報告書 |
Report Overview
The global Healthcare EDI market is projected to reach USD 7.11 billion by 2029 from USD 4.47 billion in 2024, at a CAGR of 9.7 % from 2024 to 2029.
世界のヘルスケアEDI 市場は、2024 年から 2029 年まで 9.7 % の CAGR で成長し、2024 年の 44 億 7000 万米ドルから 2029 年までに 71 億 1000 万米ドルに達すると予測されています。
The market’s growth is fuelled by the rapid digitization of healthcare records and patient data, regulatory compliance requirements, the growing volume of claims submissions, growing demand from the healthcare insurance industry, and cost reductions associated with EDI implementation. The Workgroup for Electronic Data Interchange (WEDI) estimated that EDI implementation could save USD 1 per claim for health plans and insurers, USD 1.49 for physicians, USD 0.86 for hospitals, and USD 0.83 for other parties in the US. Furthermore, according to the CAQH Index 2023, the estimated volume of claim submissions for the medical industry rose by 8% to 9.5 billion in the US in 2023. However, integration with existing healthcare IT systems, data privacy, and security constraints pose a significant challenge within this market.
市場の成長は、医療記録と患者データの急速なデジタル化、法規制遵守要件、請求提出量の増加、医療保険業界からの需要の増大、EDI導入に関連するコスト削減によって促進されています。電子データ交換ワークグループ (WEDI) は、EDI の導入により、米国内の医療保険と保険会社では請求 1 件あたり 1 米ドル、医師では 1.49 米ドル、病院では 0.86 米ドル、その他の当事者では 0.83 米ドルを節約できると試算しています。さらに、CAQH Index 2023 によると、2023 年の米国における医療業界の請求申請件数は 8% 増加して 95 億件に達すると推定されています。しかしながら、既存の医療 IT システムとの統合、データプライバシー、セキュリティ上の制約が、この市場内で大きな課題となっています。
“Point-to-point EDI held the largest market share in the healthcare EDI market in 2023.”
The healthcare EDI market is segmented based on transmission type into Value Added Network (VAN) EDI and point-to-point EDI. The point-to-point EDI segment held the largest market share in 2023. Point-to-point EDI, also known as direct EDI, establishes a single line of exchange between the involved partners, requiring them to communicate with each other individually. In the healthcare industry, point-to-point EDI is used by healthcare organizations to connect with clearinghouses or payers directly using an FTP or EDIINT (EDI over the Internet) software, thereby providing users greater control and security over their data. Reduction in intermediary costs, data security, and compliance with regulatory standards are some of the significant factors propelling market growth. However, interoperability issues and setup complexities are some of the factors restraining the market growth.
“By transaction type, the claims payment segment is expected to register the fastest growth over the forecast period.”
By transaction type, the healthcare EDI market is divided into claims submission, claims status, eligibility verification, claims payment, referral certification & authorization, payment remittance, and other EDI transactions. The claims payment segment is projected to be the fastest-growing segment over the forecast year. EDI in claims payment typically involves the automation of payment exchange between payers and providers, wherein the payment is sent directly and electronically from payers to providers through a value-added network (VAN). According to the CAQH Index 2023, fully electronic claim payment could lead to a potential cost savings opportunity of USD 524 million annually for the medical industry. The increasing demand for quick claim adjudication, the rising adoption of electronic claims payment processes by healthcare payers, and the growing complexity of reimbursement models are some of the major factors driving the market growth.
“Asia Pacific is estimated to register the highest CAGR over the forecast period.”
The Healthcare EDI market is segmented segments, namely, North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The healthcare EDI market in Asia Pacific is projected to register at the highest CAGR rate during the forecast period. The growth of this region is due to growth in healthcare infrastructure, government initiatives to modernize and digitalize the healthcare industry, and growth in the health insurance industry. Countries such as Japan and China are focusing on developing cost-effective solutions emphasizing the importance of real-time public health data sharing, rapid growth in healthcare insurance coverage, growth in cross-border healthcare services, adopting advanced technologies, and regulatory mandates for healthcare data standardization (especially in China and Japan) which bolster the Asia Pacific market growth. For instance, the implementation of the Healthy China 2030 Plan is driving the country’s health insurance system and subsequent HCIT adoption. China expects to achieve health equity by 2030. Moreover, growing medical tourism, rising healthcare expenditure, increased health insurance penetration, and growing government support are other factors augmenting the market growth.
Breakdown of supply-side primary interviews by company type, designation, and region:
- By Company Type: Tier 1 (40%), Tier 2 (35%), and Tier 3 (25%)
- By Designation: Managers (40%), Directors (35%), and Others (25%)
- By Region: North America (40%), Europe (30%), Asia Pacific (20%), Latin America (5%) and Middle East Africa (5%)
List of Companies Profiled in the Report
o McKESSON CORPORATION (US)
o UnitedHealth Group Incorporated (US)
o IBM (US)
o Cognizant (US)
o Boomi (US)
o True Commerce, Inc. (US)
o athenahealth (US)
o Axway (US)
o Experian Information Solutions, Inc. (US)
o Veradigm LLC (US)
o The SSI Group, LLC (US)
o NTT DATA Group Corporation (Japan)
o Comarch SA. (Poland)
o Availity, LLC. (US)
o Quadax, Inc. (US)
o Waystar. (US)
o PLEXIS Healthcare Systems (US)
o Inovalon. (US)
o 123 EDI (US)
o Cirius Group, Inc. (US)
o Epicor Software Corporation (US)
o OSP Labs (US)
o Nalashaa. (US)
o WNS (US)
o PilotFish, Inc. (US)
o Cleo (US)
Research Coverage
This research report categorizes the Healthcare EDI market by component (services [managed services and professional services], and software), transmission type (VAN EDI, and point-to-point EDI), end user (Healthcare providers, healthcare payers, medical device companies, pharmaceutical and biotechnology companies, and pharmacies), and region. The scope of the report covers detailed information regarding the major factors, such as drivers, restraints, challenges, and opportunities, influencing the growth of the healthcare EDI market. A thorough analysis of the key industry players has been done to provide insights into their business overview, offerings, and key strategies such as acquisitions, collaborations, agreements, mergers, product launches & updates, partnerships, expansions, and other recent developments associated with the healthcare EDI market. Competitive analysis of upcoming startups in the healthcare EDI market ecosystem is covered in this report.
Reasons to Buy the Report
The report will help market leaders/new entrants in this market with information on the closest approximations of the revenue numbers for the overall healthcare EDI market and the subsegments. This report will help stakeholders understand the competitive landscape and gain more insights to better position their businesses and plan suitable go-to-market strategies. The report also helps stakeholders understand the market pulse and provides information on key market drivers, restraints, challenges, and opportunities.
The report provides insights on the following pointers:
- Analysis of key drivers (supportive regulations for transaction processes, growing necessity to reduce healthcare costs, reduction in costs and improved operational efficiency with healthcare EDI software, rising demand for streamlined claims management, API integration accelerating claims management), restraints (ensuring data security is a major concern for both patients and EDI Users, elevated costs associated with implementing EDI software), opportunities (rising trend in outsourcing EDI services, adoption of ICD-11 standards, utilizing real-time data exchange, telehealth and remote monitoring expansion), and challenges (integration of diverse healthcare IT solutions across the industry, needs and limitations of end users, interoperability issues in legacy systems, complexities in transactions and healthcare network) influencing the growth of the healthcare EDI market
- Product Development/Innovation: Detailed insights on upcoming technologies, research & development activities, and new product & service launches in the healthcare EDI market
- Market Development: Comprehensive information about lucrative markets – the report analyses the healthcare EDI market across varied regions.
- Market Diversification: Exhaustive information about new products & services, untapped geographies, recent developments, and investments in the healthcare EDI market
- Competitive Assessment: In-depth assessment of market shares, growth strategies, and service offerings of leading players such as McKESSON CORPORATION (US), UnitedHealth Group Incorporated (US), Cognizant (US), IBM (US), Veradigm LLC (US), athenahealth (US), Axway (US), Boomi (US), and True Commerce, Inc. (US), etc. among others in healthcare EDI market.
Table of Contents
1 INTRODUCTION 35
1.1 STUDY OBJECTIVES 35
1.2 MARKET DEFINITION 35
1.3 MARKET SCOPE 36
1.3.1 MARKETS COVERED 36
1.3.2 INCLUSIONS & EXCLUSIONS 37
1.3.3 YEARS CONSIDERED 38
1.3.4 CURRENCY CONSIDERED 38
1.4 MARKET STAKEHOLDERS 39
1.5 SUMMARY OF CHANGES 39
2 RESEARCH METHODOLOGY 41
2.1 RESEARCH DATA 41
2.1.1 SECONDARY DATA 42
2.1.1.1 Key data from secondary sources 42
2.1.2 PRIMARY DATA 43
2.1.2.1 Primary sources 43
2.1.2.2 Key industry insights 44
2.1.2.3 Breakdown of primary interviews (supply side): By company type, designation, and region 44
2.2 MARKET SIZE ESTIMATION 45
2.3 MARKET BREAKDOWN AND DATA TRIANGULATION 51
2.4 MARKET SHARE ESTIMATION 52
2.5 STUDY ASSUMPTIONS 52
2.6 LIMITATIONS 52
2.6.1 METHODOLOGY-RELATED LIMITATIONS 52
2.6.2 SCOPE-RELATED LIMITATIONS 53
2.7 RISK ASSESSMENT 53
3 EXECUTIVE SUMMARY 54
4 PREMIUM INSIGHTS 58
4.1 HEALTHCARE EDI MARKET OVERVIEW 58
4.2 HEALTHCARE EDI MARKET: REGIONAL MIX 59
4.3 NORTH AMERICA: HEALTHCARE EDI MARKET, BY END USER AND COUNTRY 60
4.4 HEALTHCARE EDI MARKET: GEOGRAPHIC SNAPSHOT 61
5 MARKET OVERVIEW 62
5.1 INTRODUCTION 62
5.2 MARKET DYNAMICS 62
5.2.1 DRIVERS 63
5.2.1.1 Supportive regulations for transaction processes 63
5.2.1.2 Growing requirement to curb healthcare costs 64
5.2.1.3 Healthcare EDI software provides low costs and improved operational efficiency 65
5.2.1.4 Increasing demand for streamlined claims management 66
5.2.1.5 Acceleration of claims management with API integration 66
5.2.2 RESTRAINTS 66
5.2.2.1 Concerns associated with data security 66
5.2.2.2 High software implementation costs 69
5.2.3 OPPORTUNITIES 69
5.2.3.1 Rising trend of outsourcing EDI services 69
5.2.3.2 Adoption of ICD-11 guidelines 70
5.2.3.3 Benefits of real-time data exchange 70
5.2.3.4 Expansion of telehealth and remote monitoring capabilities 71
5.2.4 CHALLENGES 71
5.2.4.1 Integration of healthcare IT solutions 71
5.2.4.2 End-user limitations & requirements 72
5.2.4.3 Interoperability issues in legacy systems 72
5.2.4.4 Complexities associated with transactions 72
5.3 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES 73
5.4 HEALTHCARE EDI STANDARDS 73
5.4.1 ANSI X12 73
5.4.2 EDIFACT 73
5.4.3 OTHER STANDARDS 74
5.5 INDUSTRY TRENDS 75
5.5.1 ADOPTION OF INTEROPERABILITY STANDARDS 75
5.5.2 GROWTH OF VALUE-BASED CARE MODELS 75
5.5.3 INCREASING EMPHASIS ON DATA SECURITY & PRIVACY 76
5.5.4 GROWING FOCUS ON INTEGRATION PLATFORM AS A SERVICE (IPAAS) 76
5.5.5 INCREASING USE OF EDI IN SUPPLY CHAIN & DISTRIBUTION INDUSTRY 77
5.6 SUPPLY CHAIN ANALYSIS 77
5.7 ECOSYSTEM ANALYSIS 78
5.8 TECHNOLOGY ANALYSIS 80
5.8.1 KEY TECHNOLOGIES 80
5.8.1.1 REST APIS 80
5.8.1.2 Real-time data exchange 80
5.8.1.3 JSON or XML Conversion 81
5.8.1.4 EDI as a service (EDIAAS) 81
5.8.2 COMPLEMENTARY TECHNOLOGIES 81
5.8.2.1 Health information exchange 81
5.8.2.2 Electronic health records (EHRs) 81
5.8.2.3 Healthcare middleware solutions 82
5.8.3 ADJACENT TECHNOLOGIES 82
5.8.3.1 AI and ML 82
5.8.3.2 Blockchain technology 82
5.9 PORTER’S FIVE FORCES ANALYSIS 83
5.9.1 INTENSITY OF COMPETITIVE RIVALRY 84
5.9.2 BARGAINING POWER OF SUPPLIERS 84
5.9.3 BARGAINING POWER OF BUYERS 84
5.9.4 THREAT OF SUBSTITUTES 84
5.9.5 THREAT OF NEW ENTRANTS 84
5.10 KEY STAKEHOLDERS & BUYING CRITERIA 85
5.10.1 KEY STAKEHOLDERS IN BUYING PROCESS 85
5.10.2 BUYING CRITERIA 86
5.11 PRICING ANALYSIS 86
5.11.1 AVERAGE SELLING PRICE TREND, BY REGION (QUALITATIVE) 87
5.11.2 INDICATIVE PRICING ANALYSIS, BY SOFTWARE 87
5.12 REGULATORY LANDSCAPE 88
5.12.1 REGULATORY SCENARIO 88
5.12.1.1 North America 88
5.12.1.1.1 US 88
5.12.1.1.2 Canada 89
5.12.1.2 Europe 90
5.12.1.3 Asia Pacific 90
5.12.1.3.1 China 90
5.12.1.3.2 Japan 90
5.12.1.3.3 India 91
5.12.1.4 Middle East & Africa 91
5.12.1.5 Latin America 91
5.12.2 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 92
5.13 KEY CONFERENCES & EVENTS, 2025–2026 95
5.14 CASE STUDY ANALYSIS 96
5.14.1 TRANSFORMING CLAIMS MANAGEMENT WITH OPTUM CLAIMS MANAGER 96
5.14.1.1 Use case 1: Optum claims manager enhances revenue management & compliance for North Carolina 96
5.14.2 VIBRA HEALTHCARE’S SUCCESS WITH WAYSTAR 96
5.14.2.1 Use case 2: Streamlining billing and enhancing cost reduction with Waystar 96
5.14.3 ENHANCING PHARMACY CLAIMS EFFICIENCY WITH RELAYRX 97
5.14.3.1 Use case 3: Streamlining pharmacy reimbursements and improving patient outcomes 97
5.15 PATENT ANALYSIS 97
5.15.1 PATENT PUBLICATION TRENDS FOR HEALTHCARE EDI 97
5.15.2 INSIGHTS: JURISDICTION AND TOP APPLICANT ANALYSIS 98
5.16 END-USER ANALYSIS 101
5.16.1 UNMET NEEDS FOR END USERS IN HEALTHCARE EDI MARKET 101
5.16.2 END-USER EXPECTATIONS 102
5.17 INVESTMENT & FUNDING SCENARIO 102
5.18 HEALTHCARE EDI BUSINESS MODEL ANALYSIS 103
5.18.1 TOP USE CASES & MARKET POTENTIAL 104
5.18.1.1 Key use cases 105
5.18.2 CASE STUDIES OF AI/GENERATIVE AI IMPLEMENTATION 105
5.18.2.1 Case study 1: Simplification of prior authorization with Availity AuthAI 105
5.18.2.2 Case study 2: Automating claims management with implementation of AI 106
5.18.2.3 Case study 3: Enhancement of supply chain with AI-powered solution 106
5.18.3 IMPACT OF AI/GEN AI ON INTERCONNECTED & ADJACENT ECOSYSTEMS 107
5.18.3.1 Electronic health records market 107
5.18.3.2 Medical billing market 107
5.18.3.3 Healthcare revenue cycle management market 108
5.18.3.4 Health information exchange market 108
5.18.4 USER READINESS AND IMPACT ASSESSMENT 108
5.18.4.1 User readiness 108
5.18.4.1.1 Healthcare providers 108
5.18.4.1.2 Healthcare payers 108
5.18.4.2 Impact assessment 109
5.18.4.2.1 User A: Healthcare providers 109
5.18.4.2.1.1 Implementation 109
5.18.4.2.1.2 Impact 109
5.18.4.2.2 User B: Academic research institutes 109
5.18.4.2.2.1 Implementation 109
5.18.4.2.2.2 Impact 109
6 HEALTHCARE EDI MARKET, BY COMPONENT 111
6.1 INTRODUCTION 112
6.2 SERVICES 112
6.2.1 MANAGED SERVICES 114
6.2.1.1 Claims management services 115
6.2.1.1.1 Rising complexities associated with healthcare billing and regulatory requirements to boost demand 115
6.2.1.2 Supply management services 116
6.2.1.2.1 Growing focus on automation and real-time data integration to drive market 116
6.2.2 PROFESSIONAL SERVICES 117
6.2.2.1 Implementation services 119
6.2.2.1.1 Increasing demand for interoperability & integration of cloud systems to fuel market 119
6.2.2.2 Maintenance & support services 120
6.2.2.2.1 Requirement of software updates and real-time support to boost demand 120
6.2.2.3 Other services 121
6.3 SOFTWARE 122
6.3.1 SOFTWARE, BY DEPLOYMENT MODEL 123
6.3.1.1 On-premise EDI model 124
6.3.1.1.1 Enhanced control over data security to support market growth 124
6.3.1.2 Web/Cloud-based EDI model 125
6.3.1.2.1 High uptake of SaaS models to propel market 125
6.3.2 SOFTWARE, BY TRANSACTION TYPE 126
6.3.2.1 Claims management software 127
6.3.2.1.1 Claims submission 128
6.3.2.1.1.1 Growing need for improved claims accuracy and low administration costs to drive market 128
6.3.2.1.2 Claims status 129
6.3.2.1.2.1 Growing demand for claims checks with minimal manual intervention to fuel uptake 129
6.3.2.1.3 Eligibility verification 130
6.3.2.1.3.1 Growing focus on real-time patient insurance validation to boost market 130
6.3.2.1.4 Claims payment 131
6.3.2.1.4.1 Need for streamlined reimbursement processes to fuel uptake 131
6.3.2.1.5 Referral certification & authorization 132
6.3.2.1.5.1 Growing requirement for healthcare investments to drive market 132
6.3.2.1.6 Payment remittance 133
6.3.2.1.6.1 Growing focus on streamlining payment facilities to drive market 133
6.3.2.1.7 Other EDI claims transactions 134
6.3.2.2 Supply management software 135
6.3.2.2.1 Procurement management 137
6.3.2.2.1.1 Rising demand for supply chain efficiencies to fuel uptake 137
6.3.2.2.2 Inventory management 138
6.3.2.2.2.1 Growing requirement for real-time inventory tracking to drive market 138
6.3.2.2.3 Order management 139
6.3.2.2.3.1 Rising volume of medical supplies & pharmaceuticals to support market growth 139
7 HEALTHCARE EDI MARKET, BY TRANSMISSION TYPE 140
7.1 INTRODUCTION 141
7.2 VALUE-ADDED NETWORK (VAN) EDI 141
7.2.1 INCREASING DEMAND FOR CLEARINGHOUSE SERVICES TO DRIVE MARKET 141
7.3 POINT-TO-POINT EDI 143
7.3.1 UTILIZATION BY LARGE ORGANIZATIONS FOR VOLUME TRANSACTIONS TO BOOST DEMAND 143
7.4 MULTI-CHANNEL EDI 144
7.4.1 GRADUAL SHIFT TOWARDS API-BASED EXCHANGE FOR ENHANCED INTEROPERABILITY TO PROPEL MARKET 144
8 HEALTHCARE EDI MARKET, BY END USER 146
8.1 INTRODUCTION 147
8.2 HEALTHCARE PROVIDERS 147
8.2.1 HOSPITALS & CLINICS 149
8.2.1.1 Mitigation of denial claims loss to boost demand 149
8.2.2 AMBULATORY SURGERY CENTERS 150
8.2.2.1 Rising trend toward outpatient care facilities to drive market 150
8.2.3 OTHER HEALTHCARE PROVIDERS 151
8.3 HEALTHCARE PAYERS 152
8.3.1 PRIVATE PAYERS 154
8.3.1.1 Fraud prevention and improvements in traceability to fuel uptake 154
8.3.2 PUBLIC PAYERS 155
8.3.2.1 Mandatory EDI compliance for healthcare data processing to propel market 155
8.4 MEDICAL DEVICE COMPANIES 156
8.4.1 TECHNOLOGICAL INNOVATION AND SEAMLESS DEVICE PROCUREMENT REQUIREMENTS TO DRIVE MARKET 156
8.5 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES 157
8.5.1 AUTOMATION OF SUPPLY CHAIN PROCESSES TO BOOST DEMAND 157
8.6 PHARMACIES 158
8.6.1 RETAIL PHARMACY EXPANSION TO SUPPORT MARKET GROWTH 158
9 HEALTHCARE EDI MARKET, BY REGION 160
9.1 INTRODUCTION 161
9.2 NORTH AMERICA 161
9.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA 167
9.2.2 US 167
9.2.2.1 Increasing investments in rural healthcare to encourage growth 167
9.2.3 CANADA 172
9.2.3.1 Rising investments in preventive and social care to facilitate growth 172
9.3 EUROPE 176
9.3.1 MACROECONOMIC OUTLOOK FOR EUROPE 181
9.3.2 GERMANY 181
9.3.2.1 Favorable government initiatives to promote growth 181
9.3.3 UK 186
9.3.3.1 Growing digitization of healthcare infrastructure to drive market 186
9.3.4 FRANCE 190
9.3.4.1 Growing modernization efforts in healthcare to boost market 190
9.3.5 ITALY 195
9.3.5.1 Increasing focus on optimizing healthcare resources to accelerate growth 195
9.3.6 SPAIN 199
9.3.6.1 Universal public healthcare system to sustain growth 199
9.3.7 REST OF EUROPE 203
9.4 ASIA PACIFIC 208
9.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC 214
9.4.2 JAPAN 214
9.4.2.1 Innovations in digital health solutions to propel market 214
9.4.3 CHINA 219
9.4.3.1 High uptake of digitization and policy-driven expansion of health services to drive market 219
9.4.4 INDIA 223
9.4.4.1 Growing adoption of EHR solutions to fuel uptake 223
9.4.5 REST OF ASIA PACIFIC 227
9.5 LATIN AMERICA 232
9.5.1 MACROECONOMIC OUTLOOK FOR LATIN AMERICA 237
9.5.2 BRAZIL 237
9.5.2.1 Improvements in hospital management systems to drive market 237
9.5.3 MEXICO 242
9.5.3.1 Budgetary cuts and shortage of healthcare professionals to restrain market 242
9.5.4 REST OF LATIN AMERICA 246
9.6 MIDDLE EAST & AFRICA 251
9.6.1 MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA 256
9.6.2 GCC COUNTRIES 256
9.6.2.1 Rising healthcare investments for supply management to fuel uptake 256
9.6.3 REST OF MIDDLE EAST & AFRICA 261
10 COMPETITIVE LANDSCAPE 266
10.1 INTRODUCTION 266
10.2 KEY PLAYER STRATEGY/RIGHT TO WIN 266
10.2.1 OVERVIEW OF STRATEGIES ADOPTED BY PLAYERS IN HEALTHCARE EDI MARKET 266
10.3 REVENUE ANALYSIS, 2019–2023 268
10.4 MARKET SHARE ANALYSIS, 2023 269
10.4.1 SOFTWARE PROVIDERS 269
10.4.1.1 Ranking of key market players 270
10.4.2 SERVICE PROVIDERS 271
10.4.2.1 Ranking of key market players 272
10.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2023 273
10.5.1 STARS 273
10.5.2 EMERGING LEADERS 273
10.5.3 PERVASIVE PLAYERS 274
10.5.4 PARTICIPANTS 274
10.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2023 275
10.5.5.1 Company footprint 275
10.5.5.2 Component footprint 276
10.5.5.3 Transmission type footprint 277
10.5.5.4 End-user footprint 278
10.5.5.5 Region footprint 279
10.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2023 280
10.6.1 PROGRESSIVE COMPANIES 280
10.6.2 RESPONSIVE COMPANIES 280
10.6.3 DYNAMIC COMPANIES 280
10.6.4 STARTING BLOCKS 280
10.6.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2023 282
10.7 COMPANY VALUATION & FINANCIAL METRICS 283
10.7.1 FINANCIAL METRICS 283
10.7.2 COMPANY VALUATION 283
10.8 BRAND/PRODUCT COMPARISON 284
10.9 COMPETITIVE SCENARIO 285
10.9.1 PRODUCT/SERVICE LAUNCHES & ENHANCEMENTS 285
10.9.2 DEALS 286
10.9.3 OTHER DEVELOPMENTS 287
11 COMPANY PROFILES 288
11.1 KEY PLAYERS 288
11.1.1 MCKESSON CORPORATION 288
11.1.1.1 Business overview 288
11.1.1.2 Products/Services offered 289
11.1.1.2.1 Deals 290
11.1.1.2.2 Other developments 291
11.1.1.3 MnM view 291
11.1.1.3.1 Key strengths 291
11.1.1.3.2 Strategic choices 291
11.1.1.3.3 Weaknesses & competitive threats 291
11.1.2 UNITEDHEALTH GROUP 292
11.1.2.1 Business overview 292
11.1.2.2 Products/Services offered 293
11.1.2.3 Recent developments 294
11.1.2.3.1 Deals 294
11.1.2.3.2 Other developments 294
11.1.2.4 MnM view 295
11.1.2.4.1 Key strengths 295
11.1.2.4.2 Strategic choices 295
11.1.2.4.3 Weaknesses & competitive threats 295
11.1.3 COGNIZANT 296
11.1.3.1 Business overview 296
11.1.3.2 Products/Services offered 297
11.1.3.3 Recent developments 298
11.1.3.3.1 Deals 298
11.1.3.3.2 Other developments 298
11.1.3.4 MnM view 299
11.1.3.4.1 Key strengths 299
11.1.3.4.2 Strategic choices 299
11.1.3.4.3 Weaknesses & competitive threats 299
11.1.4 IBM 300
11.1.4.1 Business overview 300
11.1.4.2 Products/Services offered 302
11.1.4.3 Recent developments 302
11.1.4.3.1 Product launches 302
11.1.4.3.2 Deals 303
11.1.4.4 MnM view 304
11.1.4.4.1 Key strengths 304
11.1.4.4.2 Strategic choices 304
11.1.4.4.3 Weaknesses & competitive threats 304
11.1.5 VERADIGM LLC 305
11.1.5.1 Business overview 305
11.1.5.2 Products/Services offered 306
11.1.5.3 Recent developments 307
11.1.5.3.1 Product launches 307
11.1.5.3.2 Deals 307
11.1.5.3.3 Other developments 307
11.1.6 ATHENAHEALTH, INC. 308
11.1.6.1 Business overview 308
11.1.6.2 Products/Services offered 308
11.1.7 BOOMI, LP 309
11.1.7.1 Business overview 309
11.1.7.2 Products/Services offered 309
11.1.7.3 Recent developments 310
11.1.7.3.1 Product enhancements 310
11.1.7.3.2 Deals 311
11.1.8 EXPERIAN INFORMATION SOLUTIONS, INC. 312
11.1.8.1 Business overview 312
11.1.8.2 Products/Services offered 313
11.1.8.3 Recent developments 314
11.1.8.3.1 Product launches 314
11.1.8.3.2 Deals 315
11.1.8.3.3 Other developments 315
11.1.9 SSI GROUP LLC 316
11.1.9.1 Business overview 316
11.1.9.2 Products/Services offered 317
11.1.9.2.1 Product launches 317
11.1.10 QUADAX, INC. 318
11.1.10.1 Business overview 318
11.1.10.2 Products/Services offered 319
11.1.10.3 Recent developments 319
11.1.10.3.1 Deals 319
11.1.10.3.2 Other developments 320
11.1.11 WAYSTAR 321
11.1.11.1 Business overview 321
11.1.11.2 Products/Services offered 321
11.1.11.3 Recent developments 322
11.1.11.3.1 Product launches 322
11.1.11.3.2 Deals 322
11.1.11.3.3 Other developments 323
11.1.12 AVAILITY, LLC 324
11.1.12.1 Business overview 324
11.1.12.2 Products/Services offered 324
11.1.12.3 Recent developments 326
11.1.12.3.1 Product launches 326
11.1.12.3.2 Deals 327
11.1.12.3.3 Other developments 328
11.1.13 COMARCH SA 329
11.1.13.1 Business overview 329
11.1.13.2 Products/Services offered 330
11.1.13.3 Recent developments 331
11.1.13.3.1 Deals 331
11.1.13.3.2 Other developments 331
11.1.14 AXWAY 332
11.1.14.1 Business overview 332
11.1.14.2 Products/Services offered 333
11.1.14.3 Recent developments 334
11.1.14.3.1 Deals 334
11.1.15 PLEXIS HEALTHCARE SYSTEMS 335
11.1.15.1 Business overview 335
11.1.15.2 Products/Services offered 335
11.1.15.3 Recent developments 336
11.1.15.3.1 Other developments 336
11.1.16 TRUE COMMERCE, INC. 337
11.1.16.1 Business overview 337
11.1.16.2 Products/Services offered 337
11.1.16.3 Recent developments 338
11.1.16.3.1 Deals 338
11.1.16.3.2 Expansions 339
11.1.16.3.3 Other developments 339
11.1.17 INOVALON 340
11.1.17.1 Business overview 340
11.1.17.2 Products/Services offered 340
11.1.17.3 Recent developments 341
11.1.17.3.1 Product enhancements 341
11.1.17.3.2 Deals 341
11.1.17.3.3 Other developments 342
11.1.18 123 EDI 343
11.1.18.1 Business overview 343
11.1.18.2 Products/Services offered 343
11.1.19 NTT DATA GROUP CORPORATION 344
11.1.19.1 Business overview 344
11.1.19.2 Products/Services offered 345
11.1.19.3 Recent developments 346
11.1.19.3.1 Deals 346
11.1.20 CIRIUS GROUP, INC. 347
11.1.20.1 Business overview 347
11.1.20.2 Products/Services offered 347
11.1.21 EPICOR SOFTWARE CORPORATION 348
11.1.21.1 Business overview 348
11.1.21.2 Products/Services offered 348
11.1.21.3 Recent developments 350
11.1.21.3.1 Deals 350
11.2 OTHER PLAYERS 351
11.2.1 OSP LABS 351
11.2.2 NALASHAA 352
11.2.3 WNS 353
11.2.4 PILOTFISH, INC. 354
11.2.5 CLEO 355
12 APPENDIX 356
12.1 DISCUSSION GUIDE 356
12.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 363
12.3 CUSTOMIZATION OPTIONS 365
12.4 RELATED REPORTS 366
12.5 AUTHOR DETAILS 367
LIST OF TABLES
TABLE 1 EXCHANGE RATES UTILIZED FOR CONVERSION TO USD 38
TABLE 2 HEALTHCARE EDI MARKET: STUDY ASSUMPTION ANALYSIS 52
TABLE 3 HEALTHCARE EDI MARKET: RISK ASSESSMENT ANALYSIS 53
TABLE 4 US: LIST OF PROMINENT DATA BREACHES (2023–2024) 67
TABLE 5 HEALTHCARE EDI: KEY TRANSACTION TYPES 74
TABLE 6 HEALTHCARE EDI MARKET: ECOSYSTEM ANALYSIS 80
TABLE 7 HEALTHCARE EDI MARKET: PORTER’S FIVE FORCES ANALYSIS 83
TABLE 8 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS (%) FOR TOP 3 END USERS 85
TABLE 9 KEY BUYING CRITERIA FOR TOP 3 END USERS 86
TABLE 10 INDICATIVE PRICING OF HEALTHCARE EDI SOLUTIONS, BY SOFTWARE 87
TABLE 11 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 92
TABLE 12 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 93
TABLE 13 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 93
TABLE 14 LATIN AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 94
TABLE 15 MIDDLE EAST & AFRICA: REGULATORY BODIES, GOVERNMENT AGENCIES,
AND OTHER ORGANIZATIONS 94
TABLE 16 HEALTHCARE EDI MARKET: DETAILED LIST OF CONFERENCES & EVENTS (2025−2026) 95
TABLE 17 HEALTHCARE EDI SYSTEMS MARKET: LIST OF KEY PATENTS 100
TABLE 18 UNMET NEEDS IN HEALTHCARE EDI MARKET 101
TABLE 19 END-USER EXPECTATIONS IN HEALTHCARE EDI MARKET 102
TABLE 20 HEALTHCARE EDI MARKET, BY COMPONENT, 2022–2029 (USD MILLION) 112
TABLE 21 HEALTHCARE EDI SERVICES OFFERED BY KEY MARKET PLAYERS 113
TABLE 22 HEALTHCARE EDI SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION) 113
TABLE 23 HEALTHCARE EDI SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 113
TABLE 24 HEALTHCARE EDI MANAGED SERVICES MARKET, BY TYPE,
2022–2029 (USD MILLION) 114
TABLE 25 HEALTHCARE EDI MANAGED SERVICES MARKET, BY COUNTRY,
2022–2029 (USD MILLION) 115
TABLE 26 HEALTHCARE EDI CLAIMS MANAGEMENT SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 116
TABLE 27 HEALTHCARE EDI SUPPLY MANAGEMENT SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 117
TABLE 28 HEALTHCARE EDI PROFESSIONAL SERVICES MARKET, BY TYPE,
2022–2029 (USD MILLION) 118
TABLE 29 HEALTHCARE EDI PROFESSIONAL SERVICES MARKET, BY COUNTRY,
2022–2029 (USD MILLION) 118
TABLE 30 HEALTHCARE EDI IMPLEMENTATION SERVICES MARKET, BY COUNTRY,
2022–2029 (USD MILLION) 119
TABLE 31 HEALTHCARE EDI MAINTENANCE & SUPPORT SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 120
TABLE 32 OTHER HEALTHCARE EDI SERVICES MARKET, BY COUNTRY,
2022–2029 (USD MILLION) 121
TABLE 33 HEALTHCARE EDI SOFTWARE OFFERED BY KEY MARKET PLAYERS 122
TABLE 34 HEALTHCARE EDI SOFTWARE MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 123
TABLE 35 HEALTHCARE EDI SOFTWARE MARKET, BY DEPLOYMENT MODEL,
2022–2029 (USD MILLION) 124
TABLE 36 ON-PREMISE HEALTHCARE EDI MODELS MARKET, BY COUNTRY,
2022–2029 (USD MILLION) 125
TABLE 37 WEB/CLOUD-BASED HEALTHCARE EDI MODELS MARKET, BY COUNTRY,
2022–2029 (USD MILLION) 126
TABLE 38 HEALTHCARE EDI SOFTWARE MARKET, BY TRANSACTION TYPE,
2022–2029 (USD MILLION) 127
TABLE 39 HEALTHCARE EDI CLAIMS MANAGEMENT SOFTWARE MARKET, BY TYPE,
2022–2029 (USD MILLION) 127
TABLE 40 HEALTHCARE EDI CLAIMS MANAGEMENT SOFTWARE MARKET,
BY COUNTRY, 2022–2029 (USD MILLION) 128
TABLE 41 HEALTHCARE EDI CLAIMS SUBMISSION MARKET, BY COUNTRY,
2022–2029 (USD MILLION) 129
TABLE 42 HEALTHCARE EDI CLAIMS STATUS MARKET, BY COUNTRY,
2022–2029 (USD MILLION) 130
TABLE 43 HEALTHCARE EDI ELIGIBILITY VERIFICATION MARKET, BY COUNTRY,
2022–2029 (USD MILLION) 131
TABLE 44 HEALTHCARE EDI CLAIMS PAYMENT MARKET, BY COUNTRY,
2022–2029 (USD MILLION) 132
TABLE 45 HEALTHCARE EDI REFERRAL CERTIFICATION & AUTHORIZATION MARKET,
BY COUNTRY, 2022–2029 (USD MILLION) 133
TABLE 46 HEALTHCARE EDI PAYMENT REMITTANCE MARKET, BY COUNTRY,
2022–2029 (USD MILLION) 134
TABLE 47 OTHER HEALTHCARE EDI CLAIMS TRANSACTIONS, BY COUNTRY,
2022–2029 (USD MILLION) 135
TABLE 48 HEALTHCARE EDI SUPPLY MANAGEMENT SOFTWARE MARKET, BY TYPE,
2022–2029 (USD MILLION) 136
TABLE 49 HEALTHCARE EDI SUPPLY MANAGEMENT SOFTWARE MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 136
TABLE 50 HEALTHCARE EDI PROCUREMENT MANAGEMENT MARKET, BY COUNTRY,
2022–2029 (USD MILLION) 137
TABLE 51 HEALTHCARE EDI INVENTORY MANAGEMENT MARKET, BY COUNTRY,
2022–2029 (USD MILLION) 138
TABLE 52 HEALTHCARE EDI ORDER MANAGEMENT MARKET, BY COUNTRY,
2022–2029 (USD MILLION) 139
TABLE 53 HEALTHCARE EDI MARKET, BY TRANSMISSION TYPE, 2022–2029 (USD MILLION) 141
TABLE 54 VAN EDI TRANSMISSION TYPE: PROS AND CONS 142
TABLE 55 VAN HEALTHCARE EDI MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 142
TABLE 56 POINT-TO-POINT EDI TRANSMISSION TYPE: PROS AND CONS 143
TABLE 57 POINT-TO-POINT HEALTHCARE EDI MARKET, BY COUNTRY,
2022–2029 (USD MILLION) 144
TABLE 58 MULTI-CHANNEL EDI TRANSMISSION TYPE: PROS AND CONS 145
TABLE 59 MULTI-CHANNEL HEALTHCARE EDI MARKET, BY COUNTRY,
2022–2029 (USD MILLION) 145
TABLE 60 HEALTHCARE EDI MARKET, BY END USER, 2022–2029 (USD MILLION) 147
TABLE 61 HEALTHCARE PROVIDERS MARKET, BY TYPE, 2022–2029 (USD MILLION) 148
TABLE 62 HEALTHCARE PROVIDERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 148
TABLE 63 HEALTHCARE PROVIDERS MARKET FOR HOSPITALS & CLINICS,
BY COUNTRY, 2022–2029 (USD MILLION) 149
TABLE 64 HEALTHCARE PROVIDERS MARKET FOR AMBULATORY SURGERY CENTERS,
BY COUNTRY, 2022–2029 (USD MILLION) 151
TABLE 65 OTHER HEALTHCARE PROVIDERS MARKET, BY COUNTRY,
2022–2029 (USD MILLION) 152
TABLE 66 HEALTHCARE PAYERS MARKET, BY TYPE, 2022–2029 (USD MILLION) 153
TABLE 67 HEALTHCARE PAYERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 153
TABLE 68 HEALTHCARE PRIVATE PAYERS MARKET, BY COUNTRY,
2022–2029 (USD MILLION) 154
TABLE 69 HEALTHCARE PUBLIC PAYERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 156
TABLE 70 MEDICAL DEVICE COMPANIES MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 157
TABLE 71 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 158
TABLE 72 PHARMACIES MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 159
TABLE 73 HEALTHCARE EDI MARKET, BY REGION, 2022–2029 (USD MILLION) 161
TABLE 74 NORTH AMERICA: HEALTHCARE EDI MARKET, BY COUNTRY,
2022–2029 (USD MILLION) 163
TABLE 75 NORTH AMERICA: HEALTHCARE EDI MARKET, BY COMPONENT,
2022–2029 (USD MILLION) 163
TABLE 76 NORTH AMERICA: HEALTHCARE EDI SERVICES MARKET, BY TYPE,
2022–2029 (USD MILLION) 163
TABLE 77 NORTH AMERICA: HEALTHCARE EDI MANAGED SERVICES MARKET,
BY TYPE, 2022–2029 (USD MILLION) 164
TABLE 78 NORTH AMERICA: HEALTHCARE EDI PROFESSIONAL SERVICES MARKET,
BY TYPE, 2022–2029 (USD MILLION) 164
TABLE 79 NORTH AMERICA: HEALTHCARE EDI SOFTWARE MARKET, BY DEPLOYMENT MODEL, 2022–2029 (USD MILLION) 164
TABLE 80 NORTH AMERICA: HEALTHCARE EDI SOFTWARE MARKET, BY TRANSACTION TYPE, 2022–2029 (USD MILLION) 165
TABLE 81 NORTH AMERICA: HEALTHCARE EDI CLAIMS MANAGEMENT SOFTWARE MARKET, BY TYPE, 2022–2029 (USD MILLION) 165
TABLE 82 NORTH AMERICA: HEALTHCARE EDI SUPPLY MANAGEMENT SOFTWARE MARKET, BY TYPE, 2022–2029 (USD MILLION) 165
TABLE 83 NORTH AMERICA: HEALTHCARE EDI MARKET, BY TRANSMISSION TYPE,
2022–2029 (USD MILLION) 166
TABLE 84 NORTH AMERICA: HEALTHCARE EDI MARKET, BY END USER,
2022–2029 (USD MILLION) 166
TABLE 85 NORTH AMERICA: HEALTHCARE PROVIDERS MARKET, BY TYPE,
2022–2029 (USD MILLION) 166
TABLE 86 NORTH AMERICA: HEALTHCARE PAYERS MARKET, BY TYPE,
2022–2029 (USD MILLION) 167
TABLE 87 US: HEALTHCARE EDI MARKET, BY COMPONENT, 2022–2029 (USD MILLION) 168
TABLE 88 US: HEALTHCARE EDI SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION) 168
TABLE 89 US: HEALTHCARE EDI MANAGED SERVICES MARKET, BY TYPE,
2022–2029 (USD MILLION) 168
TABLE 90 US: HEALTHCARE EDI PROFESSIONAL SERVICES MARKET, BY TYPE,
2022–2029 (USD MILLION) 169
TABLE 91 US: HEALTHCARE EDI SOFTWARE MARKET, BY DEPLOYMENT MODEL,
2022–2029 (USD MILLION) 169
TABLE 92 US: HEALTHCARE EDI SOFTWARE MARKET, BY TRANSACTION TYPE,
2022–2029 (USD MILLION) 169
TABLE 93 US: HEALTHCARE EDI CLAIMS MANAGEMENT SOFTWARE MARKET,
BY TYPE, 2022–2029 (USD MILLION) 170
TABLE 94 US: HEALTHCARE EDI SUPPLY MANAGEMENT SOFTWARE MARKET,
BY TYPE, 2022–2029 (USD MILLION) 170
TABLE 95 US: HEALTHCARE EDI MARKET, BY TRANSMISSION TYPE,
2022–2029 (USD MILLION) 170
TABLE 96 US: HEALTHCARE EDI MARKET, BY END USER, 2022–2029 (USD MILLION) 171
TABLE 97 US: HEALTHCARE PROVIDERS MARKET, BY TYPE, 2022–2029 (USD MILLION) 171
TABLE 98 US: HEALTHCARE PAYERS MARKET, BY TYPE, 2022–2029 (USD MILLION) 171
TABLE 99 CANADA: HEALTHCARE EDI MARKET, BY COMPONENT, 2022–2029 (USD MILLION) 172
TABLE 100 CANADA: HEALTHCARE EDI SERVICES MARKET, BY TYPE,
2022–2029 (USD MILLION) 172
TABLE 101 CANADA: HEALTHCARE EDI MANAGED SERVICES MARKET,
BY TYPE, 2022–2029 (USD MILLION) 173
TABLE 102 CANADA: HEALTHCARE EDI PROFESSIONAL SERVICES MARKET, BY TYPE,
2022–2029 (USD MILLION) 173
TABLE 103 CANADA: HEALTHCARE EDI SOFTWARE MARKET, BY DEPLOYMENT MODEL,
2022–2029 (USD MILLION) 173
TABLE 104 CANADA: HEALTHCARE EDI SOFTWARE MARKET, BY TRANSACTION TYPE,
2022–2029 (USD MILLION) 174
TABLE 105 CANADA: HEALTHCARE EDI CLAIMS MANAGEMENT SOFTWARE MARKET,
BY TYPE, 2022–2029 (USD MILLION) 174
TABLE 106 CANADA: HEALTHCARE EDI SUPPLY MANAGEMENT SOFTWARE MARKET,
BY TYPE, 2022–2029 (USD MILLION) 174
TABLE 107 CANADA: HEALTHCARE EDI MARKET, BY TRANSMISSION TYPE,
2022–2029 (USD MILLION) 175
TABLE 108 CANADA: HEALTHCARE EDI MARKET, BY END USER, 2022–2029 (USD MILLION) 175
TABLE 109 CANADA: HEALTHCARE PROVIDERS MARKET, BY TYPE, 2022–2029 (USD MILLION) 175
TABLE 110 CANADA: HEALTHCARE PAYERS MARKET, BY TYPE, 2022–2029 (USD MILLION) 176
TABLE 111 EUROPE: HEALTHCARE EDI MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 177
TABLE 112 EUROPE: HEALTHCARE EDI MARKET, BY COMPONENT, 2022–2029 (USD MILLION) 177
TABLE 113 EUROPE: HEALTHCARE EDI SERVICES MARKET, BY TYPE,
2022–2029 (USD MILLION) 177
TABLE 114 EUROPE: HEALTHCARE EDI MANAGED SERVICES MARKET,
BY TYPE, 2022–2029 (USD MILLION) 178
TABLE 115 EUROPE: HEALTHCARE EDI PROFESSIONAL SERVICES MARKET,
BY TYPE, 2022–2029 (USD MILLION) 178
TABLE 116 EUROPE: HEALTHCARE EDI SOFTWARE MARKET, BY DEPLOYMENT MODEL,
2022–2029 (USD MILLION) 178
TABLE 117 EUROPE: HEALTHCARE EDI SOFTWARE MARKET, BY TRANSACTION TYPE,
2022–2029 (USD MILLION) 179
TABLE 118 EUROPE: HEALTHCARE EDI CLAIMS MANAGEMENT SOFTWARE MARKET,
BY TYPE, 2022–2029 (USD MILLION) 179
TABLE 119 EUROPE: HEALTHCARE EDI SUPPLY MANAGEMENT SOFTWARE MARKET,
BY TYPE, 2022–2029 (USD MILLION) 179
TABLE 120 EUROPE: HEALTHCARE EDI MARKET, BY TRANSMISSION TYPE,
2022–2029 (USD MILLION) 180
TABLE 121 EUROPE: HEALTHCARE EDI MARKET, BY END USER, 2022–2029 (USD MILLION) 180
TABLE 122 EUROPE: HEALTHCARE PROVIDERS MARKET, BY TYPE, 2022–2029 (USD MILLION) 180
TABLE 123 EUROPE: HEALTHCARE PAYERS MARKET, BY TYPE, 2022–2029 (USD MILLION) 181
TABLE 124 GERMANY: HEALTHCARE EDI MARKET, BY COMPONENT,
2022–2029 (USD MILLION) 182
TABLE 125 GERMANY: HEALTHCARE EDI SERVICES MARKET, BY TYPE,
2022–2029 (USD MILLION) 182
TABLE 126 GERMANY: HEALTHCARE EDI MANAGED SERVICES MARKET,
BY TYPE, 2022–2029 (USD MILLION) 182
TABLE 127 GERMANY: HEALTHCARE EDI PROFESSIONAL SERVICES MARKET,
BY TYPE, 2022–2029 (USD MILLION) 183
TABLE 128 GERMANY: HEALTHCARE EDI SOFTWARE MARKET, BY DEPLOYMENT MODEL, 2022–2029 (USD MILLION) 183
TABLE 129 GERMANY: HEALTHCARE EDI SOFTWARE MARKET, BY TRANSACTION TYPE,
2022–2029 (USD MILLION) 183
TABLE 130 GERMANY: HEALTHCARE EDI CLAIMS MANAGEMENT SOFTWARE MARKET,
BY TYPE, 2022–2029 (USD MILLION) 184
TABLE 131 GERMANY: HEALTHCARE EDI SUPPLY MANAGEMENT SOFTWARE MARKET,
BY TYPE, 2022–2029 (USD MILLION) 184
TABLE 132 GERMANY: HEALTHCARE EDI MARKET, BY TRANSMISSION TYPE,
2022–2029 (USD MILLION) 184
TABLE 133 GERMANY: HEALTHCARE EDI MARKET, BY END USER, 2022–2029 (USD MILLION) 185
TABLE 134 GERMANY: HEALTHCARE PROVIDERS MARKET, BY TYPE,
2022–2029 (USD MILLION) 185
TABLE 135 GERMANY: HEALTHCARE PAYERS MARKET, BY TYPE, 2022–2029 (USD MILLION) 185
TABLE 136 UK: HEALTHCARE EDI MARKET, BY COMPONENT, 2022–2029 (USD MILLION) 186
TABLE 137 UK: HEALTHCARE EDI SERVICE MARKET, BY TYPE, 2022–2029 (USD MILLION) 187
TABLE 138 UK: HEALTHCARE EDI MANAGED SERVICES MARKET, BY TYPE,
2022–2029 (USD MILLION) 187
TABLE 139 UK: HEALTHCARE EDI PROFESSIONAL SERVICES MARKET, BY TYPE,
2022–2029 (USD MILLION) 187
TABLE 140 UK: HEALTHCARE EDI SOFTWARE MARKET, BY DEPLOYMENT MODEL,
2022–2029 (USD MILLION) 188
TABLE 141 UK: HEALTHCARE EDI SOFTWARE MARKET, BY TRANSACTION TYPE,
2022–2029 (USD MILLION) 188
TABLE 142 UK: HEALTHCARE EDI CLAIMS MANAGEMENT SOFTWARE MARKET,
BY TYPE, 2022–2029 (USD MILLION) 188
TABLE 143 UK: HEALTHCARE EDI SUPPLY MANAGEMENT SOFTWARE MARKET,
BY TYPE, 2022–2029 (USD MILLION) 189
TABLE 144 UK: HEALTHCARE EDI MARKET, BY TRANSMISSION TYPE,
2022–2029 (USD MILLION) 189
TABLE 145 UK: HEALTHCARE EDI MARKET, BY END USER, 2022–2029 (USD MILLION) 189
TABLE 146 UK: HEALTHCARE PROVIDERS MARKET, BY TYPE, 2022–2029 (USD MILLION) 190
TABLE 147 UK: HEALTHCARE PAYERS MARKET, BY TYPE, 2022–2029 (USD MILLION) 190
TABLE 148 FRANCE: HEALTHCARE EDI MARKET, BY COMPONENT, 2022–2029 (USD MILLION) 191
TABLE 149 FRANCE: HEALTHCARE EDI SERVICES MARKET, BY TYPE,
2022–2029 (USD MILLION) 191
TABLE 150 FRANCE: HEALTHCARE EDI MANAGED SERVICES MARKET, BY TYPE,
2022–2029 (USD MILLION) 191
TABLE 151 FRANCE: HEALTHCARE EDI PROFESSIONAL SERVICES MARKET, BY TYPE,
2022–2029 (USD MILLION) 192
TABLE 152 FRANCE: HEALTHCARE EDI SOFTWARE MARKET, BY DEPLOYMENT MODEL,
2022–2029 (USD MILLION) 192
TABLE 153 FRANCE: HEALTHCARE EDI SOFTWARE MARKET, BY TRANSACTION TYPE,
2022–2029 (USD MILLION) 192
TABLE 154 FRANCE: HEALTHCARE EDI CLAIMS MANAGEMENT SOFTWARE MARKET,
BY TYPE, 2022–2029 (USD MILLION) 193
TABLE 155 FRANCE: HEALTHCARE EDI SUPPLY MANAGEMENT SOFTWARE MARKET,
BY TYPE, 2022–2029 (USD MILLION) 193
TABLE 156 FRANCE: HEALTHCARE EDI MARKET, BY TRANSMISSION TYPE,
2022–2029 (USD MILLION) 193
TABLE 157 FRANCE: HEALTHCARE EDI MARKET, BY END USER, 2022–2029 (USD MILLION) 194
TABLE 158 FRANCE: HEALTHCARE PROVIDERS MARKET, BY TYPE, 2022–2029 (USD MILLION) 194
TABLE 159 FRANCE: HEALTHCARE PAYERS MARKET, BY TYPE, 2022–2029 (USD MILLION) 194
TABLE 160 ITALY: HEALTHCARE EDI MARKET, BY COMPONENT, 2022–2029 (USD MILLION) 195
TABLE 161 ITALY: HEALTHCARE EDI SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION) 195
TABLE 162 ITALY: HEALTHCARE EDI MANAGED SERVICES MARKET, BY TYPE,
2022–2029 (USD MILLION) 196
TABLE 163 ITALY: HEALTHCARE EDI PROFESSIONAL SERVICES MARKET, BY TYPE,
2022–2029 (USD MILLION) 196
TABLE 164 ITALY: HEALTHCARE EDI SOFTWARE MARKET, BY DEPLOYMENT MODEL,
2022–2029 (USD MILLION) 196
TABLE 165 ITALY: HEALTHCARE EDI SOFTWARE MARKET, BY TRANSACTION TYPE,
2022–2029 (USD MILLION) 197
TABLE 166 ITALY: HEALTHCARE EDI CLAIMS MANAGEMENT SOFTWARE MARKET,
BY TYPE, 2022–2029 (USD MILLION) 197
TABLE 167 ITALY: HEALTHCARE EDI SUPPLY MANAGEMENT SOFTWARE MARKET,
BY TYPE, 2022–2029 (USD MILLION) 197
TABLE 168 ITALY: HEALTHCARE EDI MARKET, BY TRANSMISSION TYPE,
2022–2029 (USD MILLION) 198
TABLE 169 ITALY: HEALTHCARE EDI MARKET, BY END USER, 2022–2029 (USD MILLION) 198
TABLE 170 ITALY: HEALTHCARE PROVIDERS MARKET, BY TYPE, 2022–2029 (USD MILLION) 198
TABLE 171 ITALY: HEALTHCARE PAYERS MARKET, BY TYPE, 2022–2029 (USD MILLION) 199
TABLE 172 SPAIN: HEALTHCARE EDI MARKET, BY COMPONENT, 2022–2029 (USD MILLION) 199
TABLE 173 SPAIN: HEALTHCARE EDI SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION) 200
TABLE 174 SPAIN: HEALTHCARE EDI MANAGED SERVICES MARKET, BY TYPE,
2022–2029 (USD MILLION) 200
TABLE 175 SPAIN: HEALTHCARE EDI PROFESSIONAL SERVICES MARKET, BY TYPE,
2022–2029 (USD MILLION) 200
TABLE 176 SPAIN: HEALTHCARE EDI SOFTWARE MARKET, BY DEPLOYMENT MODEL,
2022–2029 (USD MILLION) 201
TABLE 177 SPAIN: HEALTHCARE EDI SOFTWARE MARKET, BY TRANSACTION TYPE,
2022–2029 (USD MILLION) 201
TABLE 178 SPAIN: HEALTHCARE EDI CLAIMS MANAGEMENT SOFTWARE MARKET,
BY TYPE, 2022–2029 (USD MILLION) 201
TABLE 179 SPAIN: HEALTHCARE EDI SUPPLY MANAGEMENT SOFTWARE MARKET,
BY TYPE, 2022–2029 (USD MILLION) 202
TABLE 180 SPAIN: HEALTHCARE EDI MARKET, BY TRANSMISSION TYPE,
2022–2029 (USD MILLION) 202
TABLE 181 SPAIN: HEALTHCARE EDI MARKET, BY END USER, 2022–2029 (USD MILLION) 202
TABLE 182 SPAIN: HEALTHCARE PROVIDERS MARKET, BY TYPE, 2022–2029 (USD MILLION) 203
TABLE 183 SPAIN: HEALTHCARE PAYERS MARKET, BY TYPE, 2022–2029 (USD MILLION) 203
TABLE 184 REST OF EUROPE: HEALTHCARE EDI MARKET, BY COMPONENT,
2022–2029 (USD MILLION) 204
TABLE 185 REST OF EUROPE: HEALTHCARE EDI SERVICES MARKET, BY TYPE,
2022–2029 (USD MILLION) 204
TABLE 186 REST OF EUROPE: HEALTHCARE EDI MANAGED SERVICES MARKET,
BY TYPE, 2022–2029 (USD MILLION) 205
TABLE 187 REST OF EUROPE: HEALTHCARE EDI PROFESSIONAL SERVICES MARKET,
BY TYPE, 2022–2029 (USD MILLION) 205
TABLE 188 REST OF EUROPE: HEALTHCARE EDI SOFTWARE MARKET, BY DEPLOYMENT MODEL, 2022–2029 (USD MILLION) 205
TABLE 189 REST OF EUROPE: HEALTHCARE EDI SOFTWARE MARKET, BY TRANSACTION TYPE, 2022–2029 (USD MILLION) 206
TABLE 190 REST OF EUROPE: HEALTHCARE EDI CLAIMS MANAGEMENT SOFTWARE MARKET, BY TYPE, 2022–2029 (USD MILLION) 206
TABLE 191 REST OF EUROPE: HEALTHCARE EDI SUPPLY MANAGEMENT SOFTWARE MARKET, BY TYPE, 2022–2029 (USD MILLION) 206
TABLE 192 REST OF EUROPE: HEALTHCARE EDI MARKET, BY TRANSMISSION TYPE,
2022–2029 (USD MILLION) 207
TABLE 193 REST OF EUROPE: HEALTHCARE EDI MARKET, BY END USER,
2022–2029 (USD MILLION) 207
TABLE 194 REST OF EUROPE: HEALTHCARE PROVIDERS MARKET, BY TYPE,
2022–2029 (USD MILLION) 207
TABLE 195 REST OF EUROPE: HEALTHCARE PAYERS MARKET, BY TYPE,
2022–2029 (USD MILLION) 208
TABLE 196 ASIA PACIFIC: HEALTHCARE EDI MARKET, BY COUNTRY,
2022–2029 (USD MILLION) 210
TABLE 197 ASIA PACIFIC: HEALTHCARE EDI MARKET, BY COMPONENT,
2022–2029 (USD MILLION) 210
TABLE 198 ASIA PACIFIC: HEALTHCARE EDI SERVICES MARKET, BY TYPE,
2022–2029 (USD MILLION) 210
TABLE 199 ASIA PACIFIC: HEALTHCARE EDI MANAGED SERVICES MARKET,
BY TYPE, 2022–2029 (USD MILLION) 211
TABLE 200 ASIA PACIFIC: HEALTHCARE EDI PROFESSIONAL SERVICES MARKET,
BY TYPE, 2022–2029 (USD MILLION) 211
TABLE 201 ASIA PACIFIC: HEALTHCARE EDI SOFTWARE MARKET, BY DEPLOYMENT MODEL, 2022–2029 (USD MILLION) 211
TABLE 202 ASIA PACIFIC: HEALTHCARE EDI SOFTWARE MARKET, BY TRANSACTION TYPE, 2022–2029 (USD MILLION) 212
TABLE 203 ASIA PACIFIC: HEALTHCARE EDI CLAIMS MANAGEMENT SOFTWARE MARKET,
BY TYPE, 2022–2029 (USD MILLION) 212
TABLE 204 ASIA PACIFIC: HEALTHCARE EDI SUPPLY MANAGEMENT SOFTWARE MARKET,
BY TYPE, 2022–2029 (USD MILLION) 212
TABLE 205 ASIA PACIFIC: HEALTHCARE EDI MARKET, BY TRANSMISSION TYPE,
2022–2029 (USD MILLION) 213
TABLE 206 ASIA PACIFIC: HEALTHCARE EDI MARKET, BY END-USER,
2022–2029 (USD MILLION) 213
TABLE 207 ASIA PACIFIC: HEALTHCARE PROVIDERS MARKET, BY TYPE,
2022–2029 (USD MILLION) 213
TABLE 208 ASIA PACIFIC: HEALTHCARE PAYERS MARKET, BY TYPE,
2022–2029 (USD MILLION) 214
TABLE 209 JAPAN: HEALTHCARE EDI MARKET, BY COMPONENT, 2022–2029 (USD MILLION) 215
TABLE 210 JAPAN: HEALTHCARE EDI SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION) 215
TABLE 211 JAPAN: HEALTHCARE EDI MANAGED SERVICES MARKET, BY TYPE,
2022–2029 (USD MILLION) 215
TABLE 212 JAPAN: HEALTHCARE EDI PROFESSIONAL SERVICES MARKET, BY TYPE,
2022–2029 (USD MILLION) 216
TABLE 213 JAPAN: HEALTHCARE EDI SOFTWARE MARKET, BY DEPLOYMENT MODEL,
2022–2029 (USD MILLION) 216
TABLE 214 JAPAN: HEALTHCARE EDI SOFTWARE MARKET, BY TRANSACTION TYPE,
2022–2029 (USD MILLION) 216
TABLE 215 JAPAN: HEALTHCARE EDI CLAIMS MANAGEMENT SOFTWARE MARKET,
BY TYPE, 2022–2029 (USD MILLION) 217
TABLE 216 JAPAN: HEALTHCARE EDI SUPPLY MANAGEMENT SOFTWARE MARKET,
BY TYPE, 2022–2029 (USD MILLION) 217
TABLE 217 JAPAN: HEALTHCARE EDI MARKET, BY TRANSMISSION TYPE,
2022–2029 (USD MILLION) 217
TABLE 218 JAPAN: HEALTHCARE EDI MARKET, BY END USER, 2022–2029 (USD MILLION) 218
TABLE 219 JAPAN: HEALTHCARE PROVIDERS MARKET, BY TYPE, 2022–2029 (USD MILLION) 218
TABLE 220 JAPAN: HEALTHCARE PAYERS MARKET, BY TYPE, 2022–2029 (USD MILLION) 218
TABLE 221 CHINA: HEALTHCARE EDI MARKET, BY COMPONENT, 2022–2029 (USD MILLION) 219
TABLE 222 CHINA: HEALTHCARE EDI SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION) 219
TABLE 223 CHINA: HEALTHCARE EDI MANAGED SERVICES MARKET, BY TYPE,
2022–2029 (USD MILLION) 220
TABLE 224 CHINA: HEALTHCARE EDI PROFESSIONAL SERVICES MARKET, BY TYPE,
2022–2029 (USD MILLION) 220
TABLE 225 CHINA: HEALTHCARE EDI SOFTWARE MARKET, BY DEPLOYMENT MODEL,
2022–2029 (USD MILLION) 220
TABLE 226 CHINA: HEALTHCARE EDI SOFTWARE MARKET, BY TRANSACTION TYPE,
2022–2029 (USD MILLION) 221
TABLE 227 CHINA: HEALTHCARE EDI CLAIMS MANAGEMENT SOFTWARE MARKET,
BY TYPE, 2022–2029 (USD MILLION) 221
TABLE 228 CHINA: HEALTHCARE EDI SUPPLY MANAGEMENT SOFTWARE MARKET,
BY TYPE, 2022–2029 (USD MILLION) 221
TABLE 229 CHINA: HEALTHCARE EDI MARKET, BY TRANSMISSION TYPE,
2022–2029 (USD MILLION) 222
TABLE 230 CHINA: HEALTHCARE EDI MARKET, BY END USER, 2022–2029 (USD MILLION) 222
TABLE 231 CHINA: HEALTHCARE PROVIDERS MARKET, BY TYPE, 2022–2029 (USD MILLION) 222
TABLE 232 CHINA: HEALTHCARE PAYERS MARKET, BY TYPE, 2022–2029 (USD MILLION) 223
TABLE 233 INDIA: HEALTHCARE EDI MARKET, BY COMPONENT, 2022–2029 (USD MILLION) 223
TABLE 234 INDIA: HEALTHCARE EDI SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION) 224
TABLE 235 INDIA: HEALTHCARE EDI MANAGED SERVICES MARKET, BY TYPE,
2022–2029 (USD MILLION) 224
TABLE 236 INDIA: HEALTHCARE EDI PROFESSIONAL SERVICES MARKET, BY TYPE,
2022–2029 (USD MILLION) 224
TABLE 237 INDIA: HEALTHCARE EDI SOFTWARE MARKET, BY DEPLOYMENT MODEL,
2022–2029 (USD MILLION) 225
TABLE 238 INDIA: HEALTHCARE EDI SOFTWARE MARKET, BY TRANSACTION TYPE,
2022–2029 (USD MILLION) 225
TABLE 239 INDIA: HEALTHCARE EDI CLAIMS MANAGEMENT SOFTWARE MARKET,
BY TYPE, 2022–2029 (USD MILLION) 225
TABLE 240 INDIA: HEALTHCARE EDI SUPPLY MANAGEMENT SOFTWARE MARKET,
BY TYPE, 2022–2029 (USD MILLION) 226
TABLE 241 INDIA: HEALTHCARE EDI MARKET, BY TRANSMISSION TYPE,
2022–2029 (USD MILLION) 226
TABLE 242 INDIA: HEALTHCARE EDI MARKET, BY END USER, 2022–2029 (USD MILLION) 226
TABLE 243 INDIA: HEALTHCARE PROVIDERS MARKET, BY TYPE, 2022–2029 (USD MILLION) 227
TABLE 244 INDIA: HEALTHCARE PAYERS MARKET, BY TYPE, 2022–2029 (USD MILLION) 227
TABLE 245 REST OF ASIA PACIFIC: HEALTHCARE EDI MARKET, BY COMPONENT,
2022–2029 (USD MILLION) 228
TABLE 246 REST OF ASIA PACIFIC: HEALTHCARE EDI SERVICES MARKET, BY TYPE,
2022–2029 (USD MILLION) 228
TABLE 247 REST OF ASIA PACIFIC: HEALTHCARE EDI MANAGED SERVICES MARKET,
BY TYPE, 2022–2029 (USD MILLION) 229
TABLE 248 REST OF ASIA PACIFIC: HEALTHCARE EDI PROFESSIONAL SERVICES MARKET,
BY TYPE, 2022–2029 (USD MILLION) 229
TABLE 249 REST OF ASIA PACIFIC: HEALTHCARE EDI SOFTWARE MARKET, BY DEPLOYMENT MODEL, 2022–2029 (USD MILLION) 229
TABLE 250 REST OF ASIA PACIFIC: HEALTHCARE EDI SOFTWARE MARKET, BY TRANSACTION TYPE, 2022–2029 (USD MILLION) 230
TABLE 251 REST OF ASIA PACIFIC: HEALTHCARE EDI CLAIMS MANAGEMENT SOFTWARE MARKET, BY TYPE, 2022–2029 (USD MILLION) 230
TABLE 252 REST OF ASIA PACIFIC: HEALTHCARE EDI SUPPLY MANAGEMENT SOFTWARE MARKET, BY TYPE, 2022–2029 (USD MILLION) 230
TABLE 253 REST OF ASIA PACIFIC: HEALTHCARE EDI MARKET, BY TRANSMISSION TYPE, 2022–2029 (USD MILLION) 231
TABLE 254 REST OF ASIA PACIFIC: HEALTHCARE EDI MARKET, BY END USER,
2022–2029 (USD MILLION) 231
TABLE 255 REST OF ASIA PACIFIC: HEALTHCARE PROVIDERS MARKET, BY TYPE,
2022–2029 (USD MILLION) 231
TABLE 256 REST OF ASIA PACIFIC: HEALTHCARE PAYERS MARKET, BY TYPE,
2022–2029 (USD MILLION) 232
TABLE 257 LATIN AMERICA: HEALTHCARE EDI MARKET, BY COUNTRY,
2022–2029 (USD MILLION) 233
TABLE 258 LATIN AMERICA: HEALTHCARE EDI MARKET, BY COMPONENT,
2022–2029 (USD MILLION) 233
TABLE 259 LATIN AMERICA: HEALTHCARE EDI SERVICES MARKET, BY TYPE,
2022–2029 (USD MILLION) 233
TABLE 260 LATIN AMERICA: HEALTHCARE EDI MANAGED SERVICES MARKET,
BY TYPE, 2022–2029 (USD MILLION) 234
TABLE 261 LATIN AMERICA: HEALTHCARE EDI PROFESSIONAL SERVICES MARKET,
BY TYPE, 2022–2029 (USD MILLION) 234
TABLE 262 LATIN AMERICA: HEALTHCARE EDI SOFTWARE MARKET, BY DEPLOYMENT MODEL, 2022–2029 (USD MILLION) 234
TABLE 263 LATIN AMERICA: HEALTHCARE EDI SOFTWARE MARKET, BY TRANSACTION TYPE, 2022–2029 (USD MILLION) 235
TABLE 264 LATIN AMERICA: HEALTHCARE EDI CLAIMS MANAGEMENT SOFTWARE MARKET,
BY TYPE, 2022–2029 (USD MILLION) 235
TABLE 265 LATIN AMERICA: HEALTHCARE EDI SUPPLY MANAGEMENT SOFTWARE MARKET,
BY TYPE, 2022–2029 (USD MILLION) 235
TABLE 266 LATIN AMERICA: HEALTHCARE EDI MARKET, BY TRANSMISSION TYPE,
2022–2029 (USD MILLION) 236
TABLE 267 LATIN AMERICA: HEALTHCARE EDI MARKET, BY END USER,
2022–2029 (USD MILLION) 236
TABLE 268 LATIN AMERICA: HEALTHCARE PROVIDERS MARKET, BY TYPE,
2022–2029 (USD MILLION) 236
TABLE 269 LATIN AMERICA: HEALTHCARE PAYERS MARKET, BY TYPE,
2022–2029 (USD MILLION) 237
TABLE 270 BRAZIL: HEALTHCARE EDI MARKET, BY COMPONENT, 2022–2029 (USD MILLION) 238
TABLE 271 BRAZIL: HEALTHCARE EDI SERVICES MARKET, BY TYPE,
2022–2029 (USD MILLION) 238
TABLE 272 BRAZIL: HEALTHCARE EDI MANAGED SERVICES MARKET, BY TYPE,
2022–2029 (USD MILLION) 238
TABLE 273 BRAZIL: HEALTHCARE EDI PROFESSIONAL SERVICES MARKET, BY TYPE,
2022–2029 (USD MILLION) 239
TABLE 274 BRAZIL: HEALTHCARE EDI SOFTWARE MARKET, BY DEPLOYMENT MODEL,
2022–2029 (USD MILLION) 239
TABLE 275 BRAZIL: HEALTHCARE EDI SOFTWARE MARKET, BY TRANSACTION TYPE,
2022–2029 (USD MILLION) 239
TABLE 276 BRAZIL: HEALTHCARE EDI CLAIMS MANAGEMENT SOFTWARE MARKET,
BY TYPE, 2022–2029 (USD MILLION) 240
TABLE 277 BRAZIL: HEALTHCARE EDI SUPPLY MANAGEMENT SOFTWARE MARKET,
BY TYPE, 2022–2029 (USD MILLION) 240
TABLE 278 BRAZIL: HEALTHCARE EDI MARKET, BY TRANSMISSION TYPE,
2022–2029 (USD MILLION) 240
TABLE 279 BRAZIL: HEALTHCARE EDI MARKET, BY END USER, 2022–2029 (USD MILLION) 241
TABLE 280 BRAZIL: HEALTHCARE PROVIDERS MARKET, BY TYPE, 2022–2029 (USD MILLION) 241
TABLE 281 BRAZIL: HEALTHCARE PAYERS MARKET, BY TYPE, 2022–2029 (USD MILLION) 241
TABLE 282 MEXICO: HEALTHCARE EDI MARKET, BY COMPONENT, 2022–2029 (USD MILLION) 242
TABLE 283 MEXICO: HEALTHCARE EDI SERVICES MARKET, BY TYPE,
2022–2029 (USD MILLION) 242
TABLE 284 MEXICO: HEALTHCARE EDI MANAGED SERVICES MARKET, BY TYPE,
2022–2029 (USD MILLION) 243
TABLE 285 MEXICO: HEALTHCARE EDI PROFESSIONAL SERVICES MARKET, BY TYPE,
2022–2029 (USD MILLION) 243
TABLE 286 MEXICO: HEALTHCARE EDI SOFTWARE MARKET, BY DEPLOYMENT MODEL,
2022–2029 (USD MILLION) 243
TABLE 287 MEXICO: HEALTHCARE EDI SOFTWARE MARKET, BY TRANSACTION TYPE,
2022–2029 (USD MILLION) 244
TABLE 288 MEXICO: HEALTHCARE EDI CLAIMS MANAGEMENT SOFTWARE MARKET,
BY TYPE, 2022–2029 (USD MILLION) 244
TABLE 289 MEXICO: HEALTHCARE EDI SUPPLY MANAGEMENT SOFTWARE MARKET,
BY TYPE, 2022–2029 (USD MILLION) 244
TABLE 290 MEXICO: HEALTHCARE EDI MARKET, BY TRANSMISSION TYPE,
2022–2029 (USD MILLION) 245
TABLE 291 MEXICO: HEALTHCARE EDI MARKET, BY END USER, 2022–2029 (USD MILLION) 245
TABLE 292 MEXICO: HEALTHCARE PROVIDERS MARKET, BY TYPE, 2022–2029 (USD MILLION) 245
TABLE 293 MEXICO: HEALTHCARE PAYERS MARKET, BY TYPE, 2022–2029 (USD MILLION) 246
TABLE 294 REST OF LATIN AMERICA: HEALTHCARE EDI MARKET, BY COMPONENT,
2022–2029 (USD MILLION) 247
TABLE 295 REST OF LATIN AMERICA: HEALTHCARE EDI SERVICES MARKET, BY TYPE,
2022–2029 (USD MILLION) 247
TABLE 296 REST OF LATIN AMERICA: HEALTHCARE EDI MANAGED SERVICES MARKET,
BY TYPE, 2022–2029 (USD MILLION) 247
TABLE 297 REST OF LATIN AMERICA: HEALTHCARE EDI PROFESSIONAL SERVICES MARKET,
BY TYPE, 2022–2029 (USD MILLION) 248
TABLE 298 REST OF LATIN AMERICA: HEALTHCARE EDI SOFTWARE MARKET, BY DEPLOYMENT MODEL, 2022–2029 (USD MILLION) 248
TABLE 299 REST OF LATIN AMERICA: HEALTHCARE EDI SOFTWARE MARKET, BY TRANSACTION TYPE, 2022–2029 (USD MILLION) 248
TABLE 300 REST OF LATIN AMERICA: HEALTHCARE EDI CLAIMS MANAGEMENT SOFTWARE MARKET, BY TYPE, 2022–2029 (USD MILLION) 249
TABLE 301 REST OF LATIN AMERICA: HEALTHCARE EDI SUPPLY MANAGEMENT SOFTWARE MARKET, BY TYPE, 2022–2029 (USD MILLION) 249
TABLE 302 REST OF LATIN AMERICA: HEALTHCARE EDI MARKET, BY TRANSMISSION TYPE, 2022–2029 (USD MILLION) 249
TABLE 303 REST OF LATIN AMERICA: HEALTHCARE EDI MARKET, BY END USER,
2022–2029 (USD MILLION) 250
TABLE 304 REST OF LATIN AMERICA: HEALTHCARE PROVIDERS MARKET, BY TYPE,
2022–2029 (USD MILLION) 250
TABLE 305 REST OF LATIN AMERICA: HEALTHCARE PAYERS MARKET, BY TYPE,
2022–2029 (USD MILLION) 250
TABLE 306 MIDDLE EAST & AFRICA: HEALTHCARE EDI MARKET, BY REGION,
2022–2029 (USD MILLION) 251
TABLE 307 MIDDLE EAST & AFRICA: HEALTHCARE EDI MARKET, BY COMPONENT,
2022–2029 (USD MILLION) 252
TABLE 308 MIDDLE EAST & AFRICA: HEALTHCARE EDI SERVICES MARKET, BY TYPE,
2022–2029 (USD MILLION) 252
TABLE 309 MIDDLE EAST & AFRICA: HEALTHCARE EDI MANAGED SERVICES MARKET,
BY TYPE, 2022–2029 (USD MILLION) 252
TABLE 310 MIDDLE EAST & AFRICA: HEALTHCARE EDI PROFESSIONAL SERVICES MARKET,
BY TYPE, 2022–2029 (USD MILLION) 253
TABLE 311 MIDDLE EAST & AFRICA: HEALTHCARE EDI SOFTWARE MARKET, BY DEPLOYMENT MODEL, 2022–2029 (USD MILLION) 253
TABLE 312 MIDDLE EAST & AFRICA: HEALTHCARE EDI SOFTWARE MARKET, BY TRANSACTION TYPE, 2022–2029 (USD MILLION) 253
TABLE 313 MIDDLE EAST & AFRICA: HEALTHCARE EDI CLAIMS MANAGEMENT SOFTWARE MARKET, BY TYPE, 2022–2029 (USD MILLION) 254
TABLE 314 MIDDLE EAST & AFRICA: HEALTHCARE EDI SUPPLY MANAGEMENT SOFTWARE MARKET, BY TYPE, 2022–2029 (USD MILLION) 254
TABLE 315 MIDDLE EAST & AFRICA: HEALTHCARE EDI MARKET, BY TRANSMISSION TYPE, 2022–2029 (USD MILLION) 254
TABLE 316 MIDDLE EAST & AFRICA: HEALTHCARE EDI MARKET, BY END USER,
2022–2029 (USD MILLION) 255
TABLE 317 MIDDLE EAST & AFRICA: HEALTHCARE PROVIDERS MARKET, BY TYPE,
2022–2029 (USD MILLION) 255
TABLE 318 MIDDLE EAST & AFRICA: HEALTHCARE PAYERS MARKET, BY TYPE,
2022–2029 (USD MILLION) 255
TABLE 319 GCC COUNTRIES: HEALTHCARE EDI MARKET, BY COMPONENT,
2022–2029 (USD MILLION) 257
TABLE 320 GCC COUNTRIES: HEALTHCARE EDI SERVICES MARKET, BY TYPE,
2022–2029 (USD MILLION) 257
TABLE 321 GCC COUNTRIES: HEALTHCARE EDI MANAGED SERVICES MARKET,
BY TYPE, 2022–2029 (USD MILLION) 257
TABLE 322 GCC COUNTRIES: HEALTHCARE EDI PROFESSIONAL SERVICES MARKET,
BY TYPE, 2022–2029 (USD MILLION) 258
TABLE 323 GCC COUNTRIES: HEALTHCARE EDI SOFTWARE MARKET, BY DEPLOYMENT MODEL, 2022–2029 (USD MILLION) 258
TABLE 324 GCC COUNTRIES: HEALTHCARE EDI SOFTWARE MARKET, BY TRANSACTION TYPE, 2022–2029 (USD MILLION) 258
TABLE 325 GCC COUNTRIES: HEALTHCARE EDI CLAIMS MANAGEMENT SOFTWARE MARKET, BY TYPE, 2022–2029 (USD MILLION) 259
TABLE 326 GCC COUNTRIES: HEALTHCARE EDI SUPPLY MANAGEMENT SOFTWARE MARKET, BY TYPE, 2022–2029 (USD MILLION) 259
TABLE 327 GCC COUNTRIES: HEALTHCARE EDI MARKET, BY TRANSMISSION TYPE,
2022–2029 (USD MILLION) 259
TABLE 328 GCC COUNTRIES: HEALTHCARE EDI MARKET, BY END USER,
2022–2029 (USD MILLION) 260
TABLE 329 GCC COUNTRIES: HEALTHCARE PROVIDERS MARKET, BY TYPE,
2022–2029 (USD MILLION) 260
TABLE 330 GCC COUNTRIES: HEALTHCARE PAYERS MARKET, BY TYPE,
2022–2029 (USD MILLION) 260
TABLE 331 REST OF MIDDLE EAST & AFRICA: HEALTHCARE EDI MARKET, BY COMPONENT, 2022–2029 (USD MILLION) 261
TABLE 332 REST OF MIDDLE EAST & AFRICA: HEALTHCARE EDI SERVICES MARKET,
BY TYPE, 2022–2029 (USD MILLION) 262
TABLE 333 REST OF MIDDLE EAST & AFRICA: HEALTHCARE EDI MANAGED SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION) 262
TABLE 334 REST OF MIDDLE EAST & AFRICA: HEALTHCARE EDI PROFESSIONAL SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION) 262
TABLE 335 REST OF MIDDLE EAST & AFRICA: HEALTHCARE EDI SOFTWARE MARKET,
BY DEPLOYMENT MODEL, 2022–2029 (USD MILLION) 263
TABLE 336 REST OF MIDDLE EAST & AFRICA: HEALTHCARE EDI SOFTWARE MARKET,
BY TRANSACTION TYPE, 2022–2029 (USD MILLION) 263
TABLE 337 REST OF MIDDLE EAST & AFRICA: HEALTHCARE EDI CLAIMS MANAGEMENT SOFTWARE MARKET, BY TYPE, 2022–2029 (USD MILLION) 263
TABLE 338 REST OF MIDDLE EAST & AFRICA: HEALTHCARE EDI SUPPLY MANAGEMENT SOFTWARE MARKET, BY TYPE, 2022–2029 (USD MILLION) 264
TABLE 339 REST OF MIDDLE EAST & AFRICA: HEALTHCARE EDI MARKET, BY TRANSMISSION TYPE, 2022–2029 (USD MILLION) 264
TABLE 340 REST OF MIDDLE EAST & AFRICA: HEALTHCARE EDI MARKET, BY END USER, 2022–2029 (USD MILLION) 264
TABLE 341 REST OF MIDDLE EAST & AFRICA: HEALTHCARE PROVIDERS MARKET,
BY TYPE, 2022–2029 (USD MILLION) 265
TABLE 342 REST OF MIDDLE EAST & AFRICA: HEALTHCARE PAYERS MARKET,
BY TYPE, 2022–2029 (USD MILLION) 265
TABLE 343 OVERVIEW OF STRATEGIES DEPLOYED BY KEY HEALTHCARE EDI COMPANIES 266
TABLE 344 HEALTHCARE EDI MARKET FOR SOFTWARE PROVIDERS: DEGREE OF COMPETITION 270
TABLE 345 HEALTHCARE EDI MARKET FOR SERVICE PROVIDERS: DEGREE OF COMPETITION 272
TABLE 346 HEALTHCARE EDI MARKET: COMPONENT FOOTPRINT 276
TABLE 347 HEALTHCARE EDI MARKET: TRANSMISSION TYPE FOOTPRINT 277
TABLE 348 HEALTHCARE EDI MARKET: END-USER FOOTPRINT 278
TABLE 349 HEALTHCARE EDI MARKET: REGION FOOTPRINT 279
TABLE 350 HEALTHCARE EDI MARKET: DETAILED LIST OF KEY STARTUPS/SMES 282
TABLE 351 HEALTHCARE EDI MARKET: COMPETITIVE BENCHMARKING OF KEY EMERGING PLAYERS/STARTUPS 282
TABLE 352 HEALTHCARE EDI MARKET: PRODUCT/SERVICE LAUNCHES & ENHANCEMENTS, JANUARY 2021–JANUARY 2025 285
TABLE 353 HEALTHCARE EDI MARKET: DEALS, JANUARY 2021–JANUARY 2025 286
TABLE 354 HEALTHCARE EDI MARKET: OTHER DEVELOPMENTS, JANUARY 2021–
JANUARY 2025 287
TABLE 355 MCKESSON CORPORATION: COMPANY OVERVIEW 288
TABLE 356 MCKESSON CORPORATION: PRODUCTS/SERVICES OFFERED 289
TABLE 357 MCKESSON CORPORATION: DEALS, JANUARY 2021–JANUARY 2025 290
TABLE 358 MCKESSON CORPORATION: OTHER DEVELOPMENTS,
JANUARY 2021–JANUARY 2025 291
TABLE 359 UNITEDHEALTH GROUP: COMPANY OVERVIEW 292
TABLE 360 UNITEDHEALTH GROUP: PRODUCTS/SERVICES OFFERED 293
TABLE 361 UNITEDHEALTH GROUP: DEALS, JANUARY 2021–JANUARY 2025 294
TABLE 362 UNITEDHEALTH GROUP: OTHER DEVELOPMENTS, JANUARY 2021–JANUARY 2025 294
TABLE 363 COGNIZANT: COMPANY OVERVIEW 296
TABLE 364 COGNIZANT: PRODUCTS/SERVICES OFFERED 297
TABLE 365 COGNIZANT: DEALS, JANUARY 2021–JANUARY 2025 298
TABLE 366 COGNIZANT: OTHER DEVELOPMENTS, JANUARY 2021–JANUARY 2025 298
TABLE 367 IBM: COMPANY OVERVIEW 300
TABLE 368 IBM: PRODUCTS/SERVICES OFFERED 302
TABLE 369 IBM: PRODUCT LAUNCHES, JANUARY 2021–JANUARY 2025 302
TABLE 370 IBM: DEALS, JANUARY 2021–JANUARY 2025 303
TABLE 371 VERADIGM LLC: COMPANY OVERVIEW 305
TABLE 372 VERADIGM LLC: PRODUCTS/SERVICES OFFERED 306
TABLE 373 VERADIGM LLC: PRODUCT LAUNCHES, JANUARY 2021–JANUARY 2025 307
TABLE 374 VERADIGM LLC: DEALS, JANUARY 2021–JANUARY 2025 307
TABLE 375 VERADIGM LLC: OTHER DEVELOPMENTS, JANUARY 2021–JANUARY 2025 307
TABLE 376 ATHENAHEALTH, INC.: COMPANY OVERVIEW 308
TABLE 377 ATHENAHEALTH, INC.: PRODUCTS/SERVICES OFFERED 308
TABLE 378 BOOMI, LP: COMPANY OVERVIEW 309
TABLE 379 BOOMI, LP: PRODUCTS/SERVICES OFFERED 309
TABLE 380 BOOMI, LP: PRODUCT ENHANCEMENTS, JANUARY 2021–JANUARY 2025 310
TABLE 381 BOOMI, LP: DEALS, JANUARY 2021–JANUARY 2025 311
TABLE 382 EXPERIAN INFORMATION SOLUTIONS, INC.: COMPANY OVERVIEW 312
TABLE 383 EXPERIAN INFORMATION SOLUTIONS, INC.: PRODUCTS/SERVICES OFFERED 313
TABLE 384 EXPERIAN INFORMATION SOLUTIONS, INC.: PRODUCT LAUNCHES,
JANUARY 2021–JANUARY 2025 314
TABLE 385 EXPERIAN INFORMATION SOLUTIONS, INC.: DEALS,
JANUARY 2021–JANUARY 2025 315
TABLE 386 EXPERIAN INFORMATION SOLUTIONS, INC.: OTHER DEVELOPMENTS,
JANUARY 2021–JANUARY 2025 315
TABLE 387 SSI GROUP LLC: COMPANY OVERVIEW 316
TABLE 388 SSI GROUP LLC: PRODUCTS/SERVICES OFFERED 317
TABLE 389 SSI GROUP LLC: PRODUCT LAUNCHES, JANUARY 2021–JANUARY 2025 317
TABLE 390 QUADAX, INC.: COMPANY OVERVIEW 318
TABLE 391 QUADAX, INC.: PRODUCTS/SERVICES OFFERED 319
TABLE 392 QUADAX, INC.: DEALS, JANUARY 2021–JANUARY 2025 319
TABLE 393 QUADAX, INC.: OTHER DEVELOPMENTS, JANUARY 2021–JANUARY 2025 320
TABLE 394 WAYSTAR: COMPANY OVERVIEW 321
TABLE 395 WAYSTAR: PRODUCTS/SERVICES OFFERED 321
TABLE 396 WAYSTAR: PRODUCT LAUNCHES, JANUARY 2021–JANUARY 2025 322
TABLE 397 WAYSTAR: DEALS, JANUARY 2021–JANUARY 2025 322
TABLE 398 WAYSTAR: OTHER DEVELOPMENTS, JANUARY 2021–JANUARY 2025 323
TABLE 399 AVAILITY, LLC: COMPANY OVERVIEW 324
TABLE 400 AVAILITY, LLC: PRODUCTS/SERVICES OFFERED 324
TABLE 401 AVAILITY, LLC: PRODUCT LAUNCHES, JANUARY 2021–JANUARY 2025 326
TABLE 402 AVAILITY, LLC: DEALS, JANUARY 2021–JANUARY 2025 327
TABLE 403 AVAILITY, LLC: OTHER DEVELOPMENTS, JANUARY 2021–JANUARY 2025 328
TABLE 404 COMARCH SA: COMPANY OVERVIEW 329
TABLE 405 COMARCH SA: PRODUCTS/SERVICES OFFERED 330
TABLE 406 COMARCH SA: DEALS, JANUARY 2021–JANUARY 2025 331
TABLE 407 COMARCH SA: OTHER DEVELOPMENTS, JANUARY 2021–JANUARY 2025 331
TABLE 408 AXWAY: COMPANY OVERVIEW 332
TABLE 409 AXWAY: PRODUCTS/SERVICES OFFERED 333
TABLE 410 AXWAY: DEALS, JANUARY 2021–JANUARY 2025 334
TABLE 411 PLEXIS HEALTHCARE SYSTEMS: COMPANY OVERVIEW 335
TABLE 412 PLEXIS HEALTHCARE SYSTEMS: PRODUCTS/SERVICES OFFERED 335
TABLE 413 PLEXIS HEALTHCARE SYSTEMS: OTHER DEVELOPMENTS, JANUARY 2021–JANUARY 2025 336
TABLE 414 TRUE COMMERCE, INC.: COMPANY OVERVIEW 337
TABLE 415 TRUE COMMERCE, INC.: PRODUCTS/SERVICES OFFERED 337
TABLE 416 TRUE COMMERCE, INC.: DEALS, JANUARY 2021–JANUARY 2025 338
TABLE 417 TRUE COMMERCE, INC.: EXPANSIONS, JANUARY 2021–JANUARY 2025 339
TABLE 418 TRUE COMMERCE, INC.: OTHER DEVELOPMENTS, JANUARY 2021–JANUARY 2025 339
TABLE 419 INOVALON: COMPANY OVERVIEW 340
TABLE 420 INOVALON: PRODUCTS/SERVICES OFFERED 340
TABLE 421 INOVALON: PRODUCT ENHANCEMENTS, JANUARY 2021–JANUARY 2025 341
TABLE 422 INOVALON: DEALS, JANUARY 2021–JANUARY 2025 341
TABLE 423 INOVALON: OTHER DEVELOPMENTS, JANUARY 2021–JANUARY 2025 342
TABLE 424 123 EDI: COMPANY OVERVIEW 343
TABLE 425 123 EDI: PRODUCTS/SERVICES OFFERED 343
TABLE 426 NTT DATA GROUP CORPORATION: COMPANY OVERVIEW 344
TABLE 427 NTT DATA GROUP CORPORATION: PRODUCTS/SERVICES OFFERED 345
TABLE 428 NTT DATA GROUP CORPORATION: DEALS, JANUARY 2021–JANUARY 2025 346
TABLE 429 CIRIUS GROUP, INC.: COMPANY OVERVIEW 347
TABLE 430 CIRIUS GROUP, INC.: PRODUCTS/SERVICES OFFERED 347
TABLE 431 EPICOR SOFTWARE CORPORATION: COMPANY OVERVIEW 348
TABLE 432 EPICOR SOFTWARE CORPORATION: PRODUCTS/SERVICES OFFERED 348
TABLE 433 EPICOR SOFTWARE CORPORATION: DEALS, JANUARY 2021–JANUARY 2025 350
LIST OF FIGURES
FIGURE 1 RESEARCH DESIGN 41
FIGURE 2 MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS 45
FIGURE 3 HEALTHCARE EDI MARKET: REVENUE SHARE ANALYSIS ILLUSTRATION 46
FIGURE 4 BOTTOM-UP APPROACH: END-USER SPENDING ON HEALTHCARE EDI 47
FIGURE 5 HEALTHCARE EDI MARKET: CAGR PROJECTION FROM ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES (2024–2029) 48
FIGURE 6 CAGR PROJECTION: SUPPLY-SIDE ANALYSIS 49
FIGURE 7 TOP-DOWN APPROACH 49
FIGURE 8 DATA TRIANGULATION METHODOLOGY 51
FIGURE 9 HEALTHCARE EDI MARKET, BY TRANSMISSION TYPE, 2024 VS. 2029
(USD MILLION) 54
FIGURE 10 HEALTHCARE EDI MARKET, BY COMPONENT, 2024 VS. 2029 (USD MILLION) 55
FIGURE 11 HEALTHCARE EDI SOFTWARE MARKET, BY DEPLOYMENT MODEL, 2024 VS. 2029 (USD MILLION) 55
FIGURE 12 HEALTHCARE EDI MARKET, BY END USER, 2024 VS. 2029 (USD MILLION) 56
FIGURE 13 GEOGRAPHIC SNAPSHOT OF HEALTHCARE EDI MARKET 57
FIGURE 14 LOW COST AND ENHANCED OPERATIONAL EFFICIENCY ASSOCIATED WITH HEALTHCARE EDI SOFTWARE TO PROPEL MARKET 58
FIGURE 15 ASIA PACIFIC REGION TO DOMINATE MARKET DURING FORECAST PERIOD 59
FIGURE 16 HEALTHCARE PROVIDERS SEGMENT IN US ACCOUNTED FOR LARGEST MARKET SHARE IN 2023 60
FIGURE 17 CHINA TO REGISTER HIGHEST GROWTH RATE DURING FORECAST PERIOD 61
FIGURE 18 HEALTHCARE EDI MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES,
AND CHALLENGES 62
FIGURE 19 US NON-FEDERAL ACUTE CARE HOSPITALS INTEROPERABILITY, 2021−2023 64
FIGURE 20 MEDICAL PLAN ADOPTION OF ELECTRONIC ADMINISTRATIVE TRANSACTIONS, CAQH INDEX (2021−2023) 65
FIGURE 21 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES IN
HEALTHCARE EDI MARKET 73
FIGURE 22 VALUE-BASED CARE THROUGH EFFICIENT DATA EXCHANGE 76
FIGURE 23 HEALTHCARE EDI MARKET: SUPPLY CHAIN ANALYSIS 78
FIGURE 24 HEALTHCARE EDI MARKET: ECOSYSTEM ANALYSIS 79
FIGURE 25 HEALTHCARE EDI MARKET: PORTER’S FIVE FORCES ANALYSIS 83
FIGURE 26 KEY STAKEHOLDERS ON BUYING PROCESS FOR TOP 3 END USERS 85
FIGURE 27 KEY BUYING CRITERIA FOR TOP 3 END USERS 86
FIGURE 28 PATENT PUBLICATION TRENDS (JANUARY 2015–DECEMBER 2024) 98
FIGURE 29 TOP APPLICANT COUNTRIES/REGIONS FOR HEALTHCARE EDI PATENT DOCUMENTS 98
FIGURE 30 TOP APPLICANTS AND OWNERS (COMPANIES/INSTITUTES) FOR HEALTHCARE EDI (JANUARY 2015–DECEMBER 2024) 99
FIGURE 31 FUNDING ACTIVITIES IN HEALTHCARE EDI MARKET 102
FIGURE 32 IMPACT OF GENERATIVE AI ON HEALTHCARE EDI SOLUTIONS 104
FIGURE 33 IMPACT OF GEN AI ON INTERCONNECTED & ADJACENT ECOSYSTEMS 107
FIGURE 34 NORTH AMERICA: HEALTHCARE EDI MARKET SNAPSHOT 162
FIGURE 35 ASIA PACIFIC: HEALTHCARE EDI MARKET SNAPSHOT 209
FIGURE 36 REVENUE ANALYSIS OF KEY PLAYERS IN HEALTHCARE EDI MARKET,
2019–2023 (USD BILLION) 268
FIGURE 37 MARKET SHARE ANALYSIS OF SOFTWARE PROVIDERS IN HEALTHCARE EDI MARKET (2023) 269
FIGURE 38 RANKING OF KEY PLAYERS IN HEALTHCARE EDI MARKET, BY SOFTWARE PROVIDER (2023) 270
FIGURE 39 MARKET SHARE ANALYSIS OF SERVICE PROVIDERS IN
HEALTHCARE EDI MARKET (2023) 271
FIGURE 40 RANKING OF KEY PLAYERS IN HEALTHCARE EDI MARKET, BY SERVICE
PROVIDER (2023) 272
FIGURE 41 HEALTHCARE EDI MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2023 274
FIGURE 42 HEALTHCARE EDI MARKET: COMPANY FOOTPRINT 275
FIGURE 43 HEALTHCARE EDI MARKET: COMPANY EVALUATION MATRIX
(STARTUPS/SMES), 2023 281
FIGURE 44 EV/EBITDA OF KEY VENDORS 283
FIGURE 45 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF HEALTHCARE EDI VENDORS 283
FIGURE 46 HEALTHCARE EDI MARKET: BRAND/PRODUCT COMPARATIVE ANALYSIS 284
FIGURE 47 MCKESSON CORPORATION: COMPANY SNAPSHOT (2023) 289
FIGURE 48 UNITEDHEALTH GROUP: COMPANY SNAPSHOT (2023) 293
FIGURE 49 COGNIZANT: COMPANY SNAPSHOT (2023) 297
FIGURE 50 IBM: COMPANY SNAPSHOT (2023) 301
FIGURE 51 VERADIGM LLC: COMPANY SNAPSHOT (2021) 306
FIGURE 52 EXPERIAN INFORMATION SOLUTIONS, INC.: COMPANY SNAPSHOT (2023) 313
FIGURE 53 COMARCH SA: COMPANY SNAPSHOT (2023) 330
FIGURE 54 AXWAY: COMPANY SNAPSHOT (2023) 333
FIGURE 55 NTT DATA GROUP CORPORATION: COMPANY SNAPSHOT (2023) 345
MarketsandMarkets（マーケッツアンドマーケッツ）は世界中の企業に高い評価を得ており、著名メディアでの引用頻度も高い、インドの最大手級の市場調査会社です。広範な市場を対象にした市場調査レポートを出版しています。
※MarketsandMarketsの調査レポートはほぼ全タイトルご注文後、最短3時間～12時間以内（営業日基準）にご納品可能です。
ライセンス別価格表
調査会社の事情により予告なしに変更されることがございます。最新の状況およびその他のパターンについてはお問い合わせください。
ライセンスタイプ1
| シングルユーザ | マルチユーザ | コーポレート | エンタープライズサイト |
| USD4,950 | USD6,650 | USD8,150 | USD10,000 |
ライセンスタイプ2
| シングルユーザ | マルチユーザ | コーポレート | エンタープライズサイト |
| USD7,150 | USD8,500 | USD9,650 | USD11,000 |
ライセンスタイプ3
| シングルユーザ | マルチユーザ | コーポレート | エンタープライズサイト |
| USD8,150 | お問合せください | お問合せください | お問合せください |
ライセンスタイプ4
| シングルユーザ | マルチユーザ | コーポレート | エンタープライズサイト |
| USD9,000 | USD10,500 | USD12,000 | USD13,500 |
ミニレポート ※定性調査にフォーカスした調査レポートです。詳細はお問合せください。
| シングルユーザ | コーポレート |
| USD 2,650 | USD 4,250 |
ご購入に関するご案内
価格・納期について
- 価格
- ウェブサイトに記載の外貨（定価）を見積日のTTSレートで換算後消費税を加えた金額が弊社からの請求金額になります。見積金額はレート変動に関係なく見積書発行日より2週間有効です。手数料（ハンドリングチャージ）無料。
- ライセンス
- シングルユーザライセンス
- 1名のみレポートファイルのご利用が可能です。
- マルチユーザライセンス
- 同一企業内（関連会社除く）5名までレポートファイルのご利用が可能です。
- コーポレートライセンス
- 同一企業および100％持株会社間・人数無制限でレポートファイルのご利用が可能です。
- エンタープライズサイトライセンス
- 特別ライセンスです。適用範囲についてはお問合せください。
- シングルユーザライセンス
- 納品形態
- Eメール
- 納期
- 最短3時間以内にご納品可能です。通常ご注文後24時間以内（営業日基準）
ご注文方法
- レポートページ内のお問い合わせフォームより見積もりをご請求ください。確認次第見積書と発注書をお送りいたします。既に弊社の見積書をお持ちの場合にはEメールまたはFAXでご注文ください。
その他
- 商品の性質上、ご注文後のキャンセル/返品/交換はできません。ご了承ください。
株式会社SEMABIZはMarketsandMarketsの日本に拠点をおく販売代理店として、MarketsandMarketsのレポートを販売しております。サンプルページのご依頼、見積り、レポートに関するご質問など購入前のご相談はいつでもお気軽にご連絡ください。
最新調査レポート
- 自動車用アラミド繊維市場規模、シェア、動向、2030年までの世界予測 2025-12-15
- ポリヒドロキシアルカノエート (PHA) 市場規模、シェア、動向、2030年までの世界予測 2025-12-15
- 複合輸送市場規模、シェア、動向、2032年までの世界予測 2025-12-12
- 有機酸市場規模、シェア、動向、2030年までの世界予測 2025-12-11
- ハイブリッドボンディング市場規模、シェア、動向、2032年までの世界予測 2025-12-11